Repligen Corp. (RGEN)
176.93
-1.78
(-1.00%)
USD |
NASDAQ |
Oct 23, 16:00
176.66
-0.27
(-0.15%)
After-Hours: 20:00
Repligen Price to Book Value : 4.727 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 4.727 |
| October 22, 2026 | 4.775 |
| October 21, 2026 | 4.809 |
| October 20, 2026 | 4.779 |
| October 19, 2026 | 4.714 |
| October 16, 2026 | 4.687 |
| October 15, 2026 | 4.920 |
| October 14, 2026 | 4.761 |
| October 13, 2026 | 4.687 |
| October 12, 2026 | 4.609 |
| October 09, 2026 | 4.646 |
| October 08, 2026 | 4.377 |
| October 07, 2026 | 4.468 |
| October 06, 2026 | 4.672 |
| October 05, 2026 | 5.063 |
| October 02, 2026 | 4.854 |
| October 01, 2026 | 4.735 |
| September 30, 2026 | 5.136 |
| September 29, 2026 | 5.198 |
| September 28, 2026 | 5.186 |
| September 25, 2026 | 5.068 |
| September 24, 2026 | 5.094 |
| September 23, 2026 | 4.930 |
| September 22, 2026 | 4.989 |
| September 21, 2026 | 4.828 |
| Date | Value |
|---|---|
| September 18, 2026 | 4.726 |
| September 17, 2026 | 4.761 |
| September 16, 2026 | 4.620 |
| September 15, 2026 | 4.668 |
| September 14, 2026 | 4.488 |
| September 11, 2026 | 4.413 |
| September 10, 2026 | 4.400 |
| September 09, 2026 | 4.410 |
| September 08, 2026 | 4.503 |
| September 04, 2026 | 4.478 |
| September 03, 2026 | 4.532 |
| September 02, 2026 | 4.620 |
| September 01, 2026 | 4.542 |
| August 31, 2026 | 4.835 |
| August 28, 2026 | 4.709 |
| August 27, 2026 | 4.863 |
| August 26, 2026 | 4.817 |
| August 25, 2026 | 4.854 |
| August 24, 2026 | 4.852 |
| August 21, 2026 | 4.839 |
| August 20, 2026 | 4.817 |
| August 19, 2026 | 4.712 |
| August 18, 2026 | 4.439 |
| August 17, 2026 | 4.516 |
| August 14, 2026 | 4.457 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anika Therapeutics, Inc. | 2.088 |
| Precigen, Inc. | 50.85 |
| Liquidia Corp. | 19.48 |
| Harmony Biosciences Holdings, Inc. | 2.102 |
| Agilent Technologies, Inc. | 6.628 |
Price to Book Value Related Metrics
| PE Ratio | 241.15 |
| PS Ratio | 12.76 |
| Price to Free Cash Flow | 90.95 |
| Price | 176.93 |
| Earnings Yield | 0.41% |
| Market Cap | 9.984B |
| Operating PE Ratio | 141.25 |
| Normalized PE Ratio | 216.77 |